Boston Children's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT01782547
Hospitalization of youth with established diabetes is both costly and frequently preventable. Poor glycemic control is a risk factor for hospitalization and is also associated with adolescent age and lower socioeconomic status. This is a randomized, controlled trial for high-risk adolescent youth with T1DM and suboptimal glycemic control with an intervention arm and usual care control arm matched for frequency of contacts. There will be 110 subjects with T1DM and HbA1c>8%, aged 13 to 17 years, recruited from the Diabetes Program at Boston Children's Hospital and followed for 6 months. The intervention will be implemented by a diabetes nurse educator and social worker, who will each have monthly contact with the adolescent and a parent/guardian through a telehealth (videoconference) visit. Care will be guided by a diabetes action plan. Telehealth interventions have been utilized successfully in both adults and youth with diabetes. They facilitate frequent contact with the care team allowing barriers to adherence to be addressed, education to be reinforced, care plans to be updated, and diabetes-specific family support to be provided.
Looking for future studies?
Notify Me13 year–17 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Monthly videoconference with diabetes nurse educator; Monthly videoconference with social worker; Diabetes action plan;
Standard diabetes care- typically a visit with a diabetes health care provider every 3 months and referrals to a dietitian or mental health specialist as deemed appropriate; Study participation reminder cards twice per month
Time frame: baseline and 6 months
Change in hemoglobin A1c over 6 months
Time frame: At 6 months
proportion of patients meeting the American Diabetes Association target for optimal glycemic control in this age group, which is <7.5%
Time frame: Up to 6 months
number of diabetes-related hospitalizations, ED visits, and episodes of severe hypoglycemia
Time frame: Baseline and 6 months
change over 6 months assessed by questionnaire
Time frame: Baseline and 6 months
change over 6 months assessed by questionnaire
Time frame: Baseline and 6 months
change over 6 months assessed by questionnaire
Time frame: Baseline and 6 months
change over 6 months assessed by questionnaire
Time frame: Baseline and 6 months
Change over 6 months assessed by questionnaire
Time frame: Up to 6 months
Direct medical costs include planned intervention costs and medical costs that are expected to change as a result of the intervention.
Time frame: Baseline and 6 months
assessed by questionnaire
Time frame: Baseline and 6 months
assessed by questionnaire
Time frame: At 6 months
satisfaction, engagement, visit characteristics
Boston Children's Hospital
Other
Telehealth Intervention for Youth With Type 1 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07561086
Autoimmune Diseases, Diabetes Mellitus
Marsá Maţrūḩ, Mersa Matrouh, Egypt
View Trial DetailsNCT07177404
Autoimmune Diseases, Diabete Mellitus
Derby, United Kingdom
View Trial DetailsNCT03475108
Autoimmune Diseases, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00639964
Autoimmune Diseases, Diabetes Mellitus
Lille, France
View Trial Details